Evidence map›Paper›PMID 35440846›Full record

ReviewParticle & particle systems characterization : measurement and description of particle properties and behavior in powders and other disperse systems2022

Nanotechnology: A Potential Weapon to Fight against COVID-19.

Atul K Tiwari, Anupa Mishra, Govind Pandey, Munesh K Gupta, Prem C Pandey

Open access · hybridAbstract readReview
In one paragraph

Review in Particle & particle systems characterization : measurement and description of particle properties and behavior in powders and other disperse systems, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Nanotechnology: A Potential Weapon to Fight against COVID-19.Particle & particle systems characterization : measurement and description of particle properties and behavior in powders and other disperse systems · 2022
    Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Atul K TiwariDepartment of Chemistry Indian Institute of Technology (BHU) Varanasi Uttar Pradesh 221005 India.ORCID https://orcid.org/0000-0003-3188-3566
Anupa MishraDepartment of Microbiology Dr. R.M.L. Awadh University Ayodhya Uttar Pradesh 224001 India.
Govind PandeyDepartment of Paediatrics King George Medical University Lucknow Uttar Pradesh 226003 India.
Munesh K GuptaDepartment of Microbiology Institute of Medical Sciences Banaras Hindu University Varanasi Uttar Pradesh 221005 India.
Prem C PandeyDepartment of Chemistry Indian Institute of Technology (BHU) Varanasi Uttar Pradesh 221005 India.ORCID https://orcid.org/0000-0002-6053-902X
Indian Institute of Technology BHU · INDr. Ram Manohar Lohia Avadh University · INInstitute of Medical Sciences · INKing George's Medical University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The COVID-19 infections have posed an unprecedented global health emergency, with nearly three million deaths to date, and have caused substantial economic loss globally. Hence, an urgent exploration of effective and safe diagnostic/therapeutic approaches for minimizing the threat of this highly pathogenic coronavirus infection is needed. As an alternative to conventional diagnosis and antiviral agents, nanomaterials have a great potential to cope with the current or even future health emergency situation with a wide range of applications. Fundamentally, nanomaterials are physically and chemically tunable and can be employed for the next generation nanomaterial-based detection of viral antigens and host antibodies in body fluids as antiviral agents, nanovaccine, suppressant of cytokine storm, nanocarrier for efficient delivery of antiviral drugs at infection site or inside the host cells, and can also be a significant tool for better understanding of the gut microbiome and SARS-CoV-2 interaction. The applicability of nanomaterial-based therapeutic options to cope with the current and possible future pandemic is discussed here.

Indexed as

antiviral drugsbiosensorsdrug deliverynanoformulationsnanotechnologyvaccines

Identifiers

PMID35440846
PMCPMC9011707
OpenAlexW3217759581

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.